One of the effects of the medication is that it can lead to extremely low blood sugar in patients without a history of low blood sugar or any blood sugar problems
This context can support a more informed conversation with your provider about whether standard weekly dosing, dose escalation, or (in rare cases) interval adjustment aligns with your genetic predispositions
Most cases of GLP-1 induced gastroparesis can be reversed
They already make the most potent weight-loss medication out there, Low Wang said, referring to Zepbound and Mounjaro
In a pool of Study 1 and 2, hair loss was reported more frequently in female than male patients in the ZEPBOUND (7.1% female versus 0.5% male) and placebo (1.3% female versus 0% male) treatment groups
The SURPASS program (multiple trials, NEJM and Lancet 2021 to 2022) supports the Mounjaro diabetes label